Alira Health

Alira Health

Global MedTech CDMO M&A Update

H1 2023

The global MedTech CDMO industry in the first half of 2023 saw a sustained volume of M&A transactions, in line with H2 2022. We have compiled a list of implications of robust market activity indicating a continued high interest of global investors in MedTech CDMO despite a worsening economy and credit crunch.

Download this overview and discover:

  • Key market insights and industry dynamics
  • Deal activities and their implications
  • Factors driving the growth and evolution
Global CDMO Deals Update

Fill in the form to download Global MedTech CDMO M&A H1 2023 Update. Have questions? Reach out to us at [email protected].

 

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.